Deborah DaPore, RPh, gives a price-difference example of a brand-name drug and its generic counterpart.
Read the full transcript »
Generic Ambien came off patent about two months ago when it first came on the market. Some of the change was selling at a discounted price of $87.90 for 30. We were selling it at $19.99. So the difference that you’re seeing the cost of the drug is $3.70 for a 100. The changes are marking it up a lot more because of their overhead but the cost of the drug has substantially gone down. Brand name Ambien CR is now on the market because the patent has come off and the reason that they’ve done the CR is because they lost their patent on the Ambien 10. So now you see the Ambien CR 6.25, the Ambien CR 12.5and the patients have to pay a lot more money for those. You have to explain to people the research and developments that the big companies do to develop the drug and how many millions of dollars it takes to bring a drug to market, people really don’t want to hear that. They’re not interested in that however if you say, if research and development stops, then we have eliminated the possibility of new drugs coming on the market that can treat, move disease states and they don’t want that either.